Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
English (EN)
NITAG documentation
2021
Recommendation
Clear all
Type of publications
NITAG documentation
(84)
Topics
Recommendation
(84)
Available to download in languages
English (EN)
(84)
French (FR)
(36)
Spanish (ES)
(11)
German (DE)
(7)
Swedish (SV)
(1)
Regions
Africa
(13)
Americas
(24)
Europe
(35)
South-East Asia
(1)
Western Pacific
(11)
Countries
Diseases
COVID-19
(84)
Ebola
(1)
Herpes zoster
(1)
Influenza
(3)
Poliomyelitis
(1)
Rotavirus
(2)
Varicella
(1)
Vaccine topics
Target population
Adults
(2)
Older adults
(1)
Pregnant women
(2)
Risk group
(1)
Publication date
2021
(84)
2024
(2)
2023
(16)
2022
(43)
2020
(14)
84 results found
2021
∙
ACIP
Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years
2021
∙
ACIP
Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines
2021
Interim Recommendations on the Use of COVID-19 Vaccines in Nigeria
2021
∙
JCVI
JCVI advice on the UK vaccine response to the Omicron variant
2021
∙
JCVI
JCVI advice on Third primary COVID-19 vaccine dose for people who are immunosuppressed - 1 September, 2021
2021
∙
JCVI
JCVI advice to mitigate impact of B1.617.2 variant - 14 May 2021
2021
∙
JCVI
JCVI advises on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40 - 7 May 2021
2021
∙
JCVI
JCVI final statement on phase 2 of the COVID-19 vaccination programme: 13 April, 2021
2021
∙
JCVI
JCVI interim advice: potential COVID-19 booster vaccine programme winter 2021 to 2022 - 30 June 2021
2021
∙
JCVI, Public Health England
JCVI interim statement on phase 2 of the COVID-19 vaccination programme
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register